Want to know the latest news and articles posted on Telix Pharmaceuticals?
Then subscribe to their feed now! You can receive their updates by email, via mobile or on your personal news page on this website.
See what they recently published below.
Website title: Home - Telix Pharmaceuticals
Is this your feed? Claim it!
Melbourne (Australia) and Indianapolis (United States) | 10 March 2026
Webcast and conference call to be held today, Tuesday March 10 at 9:30 a.m. AEDT (Monday March 9 at 6:30 p.m. EDT). Investors can register at the following link:Melbourne (Australia) and Indianapolis (United States) | 2 March 2026
Telix invites investors to join a webinar with key opinion leaders to discuss a physician’s perspective on innovations in PSMA-PET/CT imaging for prostate ...
Melbourne (Australia) and Indianapolis (United States) | 28 February 2026
Telix today announces a research collaboration with University Hospital Essen on the PROMI...
27 February 2026
As a resource for analysts and investors, Telix has published a clinical data summary for TLX591-Tx (lutetium-177 rosopatamab tetraxetan), its investigational PSMA-targeted radio antibody-drug conjugate (rADC) for metastatic castration-resista...
Melbourne (Australia) and Indianapolis (United States) | February 20, 2026
Telix today announces its financial results for the year ended December 31, 2025.
FY 2025 key results